Pear Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pear Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2022.
  • Pear Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2022 was $3.68M, a 99.6% increase year-over-year.
  • Pear Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2022 was $13.5M, a 255% increase year-over-year.
  • Pear Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13.5M, a 255% increase from 2021.
  • Pear Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.81M, a 57.8% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $13.5M +$9.72M +255% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 $3.81M -$5.22M -57.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $9.03M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.